FLUCONAZOLE TABLETS

The Defense Logistics Agency awarded a single-line-item delivery order to DMS PHARMACEUTICAL GROUP INC under contract SPE2DP26F7767, issued on July 20, 2026, for the procurement of one unit of FLUCONAZOLE TABLETS with National Stock Number 6505013198247 at a fixed unit price of $59.80, resulting in a total contract value of $59.80. The award is tied to the master delivery order SPE2DX25D9900 and is classified under NAICS code 325412 for pharmaceutical preparation manufacturing. Delivery is required by August 4, 2026, to the destination point at Fort Bragg, North Carolina, with FOB terms placing full transportation responsibility and risk on the contractor. The product must comply with specific National Drug Code identifiers including NDC51407-0427-30, NDC62135-0133-30, and NDC00049-3430-30, and be marked with the manufacturer’s CAGE code, NSN, PR number 7017562969, and DIC A0A. Packaging must be shipped via the fastest traceable means, explicitly prohibiting parcel post, and must adhere to military logistics marking protocols without reference to formal MIL-STDs. Inspection and acceptance occur at the destination, with no flexibility in quantity variance permitted. The contract includes no options, additional line items, or extended performance periods. No detailed contract clauses, evaluation factors, special requirements, or representations from the offeror are documented beyond basic award and delivery data. Funding is tracked via FC Z9 and the Document Identifier Code A0A, with payment responsibility assigned to the contractor under FOB destination terms. No contracting officer, technical representative, or invoicing system details are provided, and no formal attachments or clause listings are included in the record. The absence of non-price evaluation criteria suggests the award was likely based on Lowest Price Technically Acceptable methodology, though not explicitly stated.